Report Highlights
The global blood plasma products market should reach $45.7 billion by 2027 from $33.2 billion in 2022 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2022 to 2027.
Report Includes
- 44 data tables and 30 additional tables
- An overview of the global market for blood plasma products
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
- Detailed information related to mode of delivery for blood plasma
- Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
- Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
- In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
- A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
- Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
Report Scope
This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.
The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.
In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Report Synopsis
Report Metrics | Details | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||
Forecast period considered | 2022 to 2027 | ||||||||||||||
Base year market size | $31.4 billion | ||||||||||||||
Market size forecast | $45.7 billion | ||||||||||||||
Growth rate | CAGR of 6.6% for the forecast period of 2022-2027 | ||||||||||||||
Units considered | $ Millions | ||||||||||||||
Segments covered | product type, application, end-user and region | ||||||||||||||
Regions covered | North America, Asia-Pacific, Europe, and Rest of the World | ||||||||||||||
Countries covered | U.S., Canada, U.K., Germany, France, Italy, Rest of Europe, China, India, Japan, Australia, and Rest of APAC | ||||||||||||||
Key Market Drivers |
|
||||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global blood plasma products market should reach $35.5 billion by 2023 from $25.7 billion in 2018 at a compound annual growth rate (CAGR) of 6.6% for the period 2018-2023.
Report Includes
- 52 data tables and 24 additional tables
- Industry analysis of the global market for blood plasma products
- Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
- Qualitative information related to mode of delivery for blood plasma
- Key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
- Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
- In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
- A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education
- Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.
Report Highlights
The global market for blood plasma reached $16.8 billion in 2016 and should reach $23.0 billion in 2021, growing at a compound annual growth rate (CAGR) of 6.6% from 2016 through 2021.
Report Includes
- An overview of the global markets for blood plasma products.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Analysis of the market by product, application, mode of delivery and by end user.
- Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products.
- In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion.
- A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education.
- Profiles of major players in the industry.
Related Reports
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biological therapeutic drugs is expected to increase from $452.9 billion in 2023 to $823.4 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.7% during the forecast period of 2023-2028.
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets
The global market for antithrombotic/anticoagulant drugs is estimated to grow from $31.6 billion in 2023 to reach $46.2 billion by 2028, at a compound annual growth rate (CAGR) of 7.9% from 2023 through 2028.
Artificial Blood: Global Markets to 2028
The global artificial blood market reached $23.9 million in 2022, should reach $26.1 million by 2023 and $40.5 million by 2028 with a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023-2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More